Yet Another White House Obamacare Delay: Out-Of-Pocket Caps

New Post Public Reply Private Reply Replies (1) Message Board
SaltyMutt
Yet Another White House Obamacare Delay: Out-Of-Pocket Caps Waived Until 2015

Avik Roy
8/13/2013 @ 12:59AM

(please note: The underlined words are 'clickable' links when accessed via the link at the bottom of this page)

First, there was the delay of Obamacare’s Medicare cuts until after the election. Then there was the delay of the law’s employer mandate. Then there was the announcement, buried in the Federal Register, that the administration would delay enforcement of a number of key eligibility requirements for the law’s health insurance subsidies , relying on the “ honor system ” instead. Now comes word that another costly provision of the health law—its caps on out-of-pocket insurance costs—will be delayed for one more year.

Obamacare contains a blizzard of mandates and regulations that will make health insurance more costly. One of the most significant is its caps on out-of-pocket insurance costs , such as co-pays and deductibles. Section 2707(b) of the Public Health Service Act, as added by Obamacare, requires that “a group health plan and a health insurance issuer offering group or individual health insurance coverage may not establish lifetime limits on the dollar value of benefits for the any participant or beneficiary.” Annual limits on cost-sharing are specified by Section 1302(c) of the Affordable Care Act; in addition, starting in 2014, deductibles are limited to $2,000 per year for individual plans, and $4,000 per year for family plans.

Out-of-pocket caps drive premiums upward

There’s no such thing as a free lunch. If you ban lifetime limits, and mandate lower deductibles, and cap out-of-pocket costs, premiums have to go up to reflect these changes. And unlike a lot of the “rate shock” problems we’ve been discussing, these limits apply not only to individually-purchased health insurance, but also to employer-sponsored coverage. (Self- insured employers are exempted.)

These mandates have already had drastic effects on a number of colleges and universities, which offer inexpensive, defined-cap plans to their healthy, youthful students. Premiums at Lenoir-Rhyne University in Hickory, N.C., for example, rose from $245 per student in 2011-2012 to between $2,507 in 2012-2013. The University of Puget Sound paid $165 per student in 2011-2012; their rates rose to between $1,500 and $2,000 for 2012-2013. Other schools have been forced to drop coverage because they could no longer afford it.

According to the law, the limits on out-of-pocket costs for 2014 were $6,350 for individual policies and $12,700 for family ones. But in February, the Department of Labor published a little-noticed rule delaying the cap until 2015. The delay was described yesterday by Robert Pear in the New York Times.

Delay needed to align ‘separate computer systems’

Notes Pear, “Under the [one-year delay], many group health plans will be able to maintain separate out-of-pocket limits for benefits in 2014. As a result, a consumer may be required to pay $6,350 for doctors’ services and hospital care, and an additional $6,350 for prescription drugs under a plan administered by a pharmacy benefit manager.”

The reason for the delay? “Federal officials said that many insurers and employers needed more time to comply because they used separate companies to help administer major medical coverage and drug benefits, with separate limits on out-of-pocket costs. In many cases, the companies have separate computer systems that cannot communicate with one another.”

The best part in Pear’s story is when a “senior administration official” said that “we had to balance the interests of consumers with the concerns of health plan sponsors and carriers…They asked for more time to comply.” Exactly how is it in consumers’ interests to pay far more for health insurance than they do already?

It’s not. Unless you have a serious, chronic condition, in which case you may benefit from the fact that law forces healthy people to subsidize your care. To progressives, this is the holy grail. But for economically rational individuals, it’s yet another reason to drop out of the insurance market altogether. For economically rational businesses, it’s a reason to self-insure, in order to get out from under these costly mandates.

Patient groups upset

While insurers and premium-payers will be happy with the delay—whose legal justification is dubious once again—there are groups that grumbled. Specifically, groups representing those with chronic diseases, and the pharmaceutical companies whose costly drugs they will use. “The American Cancer Society shares the concern” about the delay, says Pear, “and noted that some new cancer drugs cost $100,000 a year or more.” But a big part of the reason those drugs cost so much is because manufacturers know that government-run insurers will pay up.

“The promise of out-of-pocket limits was one of the main reasons we supported health reform,” says Theodore M. Thompson of the National Multiple Sclerosis Society. “We have wonderful new drugs, the biologics, to treat rheumatoid arthritis,” said Patience H. White of the Arthritis Foundation. “But they are extremely expensive.”

The progressive solution to every expensive problem? More subsidies. But subsidies don’t reduce the underlying cost of care. They only excuse the high prices that manufacturers and service providers already charge.

It’s one of the many aspects of Obamacare that should be repealed, if we are to combat the rate shock that the health law imposes on the vast majority of Americans. But that will require Republicans to come up with a smarter strategy than shutting down the government.

http://www.forbes.com/sites/theapothecary/201...ntil-2015/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elbit Systems Poised for Q3 2026 Earnings Reveal

Updated Category News Views 65

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Continue Reading
Penske's Q3 2026: Revenue Up, Private Deal Awaits

Updated Category News Views 27

Jumping straight into it, Penske Automotive Group (NYSE: PAG) just rolled out their quarterly numbers. The highlights? A 5% revenue bump, landing at $8.4 billion. That's nice, sure, but let's not get too cozy, there's a bigger elephant in this garage—it's the bold move to take the company private! Our old friend volatility still sends shivers down the spine of long-time...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 40

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
BlueNord Signals Strategic Shift with Vår Energi Merger

Updated Category News Views 18

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 0

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading
AppGate Rises as 2026 Leader in Digital Risk

Updated Category News Views 67

AppGate: Forging a Path in Digital Security In a world where cyber threats seem to lurk around every digital corner, snagging the title of a leader in digital risk protection from the SPARK Matrix is no small feat. Let’s dive deep into AppGate’s rise to the top in QKS Group’s 2026 evaluation. What Sets AppGate Apart? AppGate's leadership status isn't some overnight...

Continue Reading
Scams vs Identity Theft: Trauma's Dark Impact Revealed

Updated Category News Views 134

Facing the Dark Reality of Scams and Identity Theft Imagine facing a bleak financial horizon because of scams and identity theft, but the weight on your soul ain't about just numbers. That's what the Identity Theft Resource Center's 2026 Consumer Impact Report brings to light. We're talking about massive mental and emotional whirlwinds, way beyond mere dollars and cents....

Continue Reading
Kong Joins Forces with ServiceNow for AI Governance

Updated Category News Views 59

Shaping the Future of Enterprise AI When it comes to AI governance, it's not just about flashy tech jargon; it's about ensuring that enterprises can tread carefully and confidently in the AI arena. Kong, the AI Connectivity Company, is making a significant move by teaming up with ServiceNow in what's been dubbed the ServiceNow Control Tower Alliance. This collaboration...

Continue Reading
Royce Small-Cap Trust Shows Resilience Amid Volatility

Updated Category News Views 95

A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 27

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Orbit Garant's First Quarter 2026 Performance Reviewed

Updated Category News Views 157

Overview of Financial Performance Orbit Garant Drilling Inc. (TSX: OGD) has released its financial results for the first quarter of fiscal 2026, ending on September 30, 2025. During this three-month period, the company recorded a revenue of $46.7 million, marking a 3.7% decline compared to $48.4 million during the same period last year. The revenue figures reflect a range...

Continue Reading
Celebrating Leadership Excellence at Coldwell Banker 2025

Updated Category News Views 250

Celebrating Achievements in Real Estate Leadership The Leadership Awards highlight the dedication of Coldwell Banker-affiliated real estate professionals who embody the core values of the organization. Recognizing Outstanding Contributions With a strong commitment to innovation and community service, Coldwell Banker Real Estate LLC, a subsidiary of Anywhere Real Estate...

Continue Reading
U.S. Drone Production Boost Promises Growth for Key Companies

Updated Category News Views 167

Major Shift in U.S. Drone Production Policies The recent announcement from the U.S. Defense Secretary has ignited excitement in the drone manufacturing industry. On a significant day, the Secretary unveiled plans to fast-track drone production through reforms aimed at simplifying procurement processes within the Pentagon. This bold move signifies a departure from previous...

Continue Reading
Acacia Research Set for Q3 2024 Financial Results Release

Updated Category News Views 96

Exciting Announcement from Acacia Research Acacia Research Corporation (NASDAQ: ACTG) is poised to share its financial outcomes for the third quarter of 2024. This revelation is set to occur before the market opens on a significant day in November. Businesses and investors alike are eager to gain insights into the company’s latest financial endeavors. What to Expect...

Continue Reading
Revolutionizing Grocery Shopping: Deliverect's New Retail Solution

Updated Category News Views 185

Revolutionizing Grocery Retail with Deliverect's Innovative Solution Deliverect, a leader in food technology software as a service (SaaS), has introduced Deliverect Retail to enhance the digital shopping experience for groceries. This important development allows grocery retailers to operate more effectively, which leads to better sales and improves customer satisfaction....

Continue Reading